OBJECTIVE AND DESIGN: In this study, the possible protective effect of glycyrrhizin (GL), an active compound derived from licorice root, was examined on T cell-mediated liver injury in mice. MATERIALS AND METHODS: Mice were subjected to liver injury by intravenous injection of concanavalin A (Con A). They had been treated with GL (i.p.) 30 min before the injection. Liver injury was estimated by measuring serum levels of alanine aminotransaminase (ALT) and aspartate aminotransaminase (AST), and by examining liver sections with hematoxylin-eosin staining. Expression of inducible nitric oxide synthase (iNOS) mRNA and protein in the liver was determined by reverse transcription polymerase chain reaction (RT-PCR) and Western blotting. RESULTS: Serum transaminases and hepatic iNOS levels increased with time after Con A treatment. Expression of iNOS mRNA in the liver was elevated for up to 8 h, and at 8 h, GL (ED(50): 10.5 mg/kg) suppressed the increases in AST and ALT in response to Con A. An increase in iNOS mRNA expression and protein was inhibited by treatment with GL. Furthermore, GL inhibited cell infiltration and the degeneration of hepatocytes in the liver of Con A-treated mice. CONCLUSION: The present study suggests that the prevention by GL of Con A-induced hepatitis is due partly to the modulation of hepatic iNOS induction and of degeneration of hepatocytes.
OBJECTIVE AND DESIGN: In this study, the possible protective effect of glycyrrhizin (GL), an active compound derived from licorice root, was examined on T cell-mediated liver injury in mice. MATERIALS AND METHODS:Mice were subjected to liver injury by intravenous injection of concanavalin A (Con A). They had been treated with GL (i.p.) 30 min before the injection. Liver injury was estimated by measuring serum levels of alanine aminotransaminase (ALT) and aspartate aminotransaminase (AST), and by examining liver sections with hematoxylin-eosin staining. Expression of inducible nitric oxide synthase (iNOS) mRNA and protein in the liver was determined by reverse transcription polymerase chain reaction (RT-PCR) and Western blotting. RESULTS: Serum transaminases and hepatic iNOS levels increased with time after Con A treatment. Expression of iNOS mRNA in the liver was elevated for up to 8 h, and at 8 h, GL (ED(50): 10.5 mg/kg) suppressed the increases in AST and ALT in response to Con A. An increase in iNOS mRNA expression and protein was inhibited by treatment with GL. Furthermore, GL inhibited cell infiltration and the degeneration of hepatocytes in the liver of Con A-treated mice. CONCLUSION: The present study suggests that the prevention by GL of Con A-induced hepatitis is due partly to the modulation of hepatic iNOS induction and of degeneration of hepatocytes.
Authors: Y Arase; K Ikeda; N Murashima; K Chayama; A Tsubota; I Koida; Y Suzuki; S Saitoh; M Kobayashi; H Kumada Journal: Cancer Date: 1997-04-15 Impact factor: 6.860
Authors: M Yoshikawa; Y Matsui; H Kawamoto; N Umemoto; K Oku; M Koizumi; J Yamao; S Kuriyama; H Nakano; N Hozumi; S Ishizaka; H Fukui Journal: J Gastroenterol Hepatol Date: 1997-03 Impact factor: 4.029
Authors: Stephanie H Greco; Alejandro Torres-Hernandez; Aleksandr Kalabin; Clint Whiteman; Rae Rokosh; Sushma Ravirala; Atsuo Ochi; Johana Gutierrez; Muhammad Atif Salyana; Vishnu R Mani; Savitha V Nagaraj; Michael Deutsch; Lena Seifert; Donnele Daley; Rocky Barilla; Mautin Hundeyin; Yuriy Nikifrov; Karla Tejada; Bruce E Gelb; Steven C Katz; George Miller Journal: J Immunol Date: 2016-08-24 Impact factor: 5.422
Authors: Florent Duval; Jorge E Moreno-Cuevas; María Teresa González-Garza; Carmen Maldonado-Bernal; Delia Elva Cruz-Vega Journal: Int J Inflam Date: 2015-04-14